In Vivo Islet Protection by a Nuclear Import Inhibitor in a Mouse Model of Type 1 Diabetes

• Daniel J. Moore,

  Affiliations Department of Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America, Department of Pediatrics, Ian Burr Division of Endocrinology and Diabetes, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America

  ⨯
• Jozef Zienkiewicz,

  Affiliation Department of Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America

  ⨯
• Peggy L. Kendall,

  Affiliation Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America

  ⨯
• Danya Liu,

  Affiliations Department of Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America, Department of Surgery and Emory Transplant Center, Emory University, Atlanta, Georgia, United States of America

  ⨯
• Xueyan Liu,

  Affiliation Department of Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America

  ⨯
• Ruth Ann Veach,

  Affiliation Department of Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America

  ⨯
• Robert D. Collins,

  Affiliation Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America

  ⨯
• Jacek Hawiger

  * E-mail: jacek.hawiger@vanderbilt.edu

  Affiliation Department of Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America

  ⨯